Correspondence 0001193125-23-148004 from BIOCEPT INC (BIOCQ) (CIK 0001044378)
BIOCEPT INC (BIOCQ) (CIK 0001044378)
Date: May 18, 2023 · CIK: 0001044378 · Accession: 0001193125-23-148004
AI Filing Summary & Sentiment
File numbers found in text: 333-271355
Show Raw Text
CORRESP 1 filename1.htm CORRESP May 18, 2023 VIA EDGAR Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Re: Biocept, Inc. Registration Statement on Form S-1 (File No. 333-271355) – Withdrawal of Acceleration Request Ladies and Gentlemen: Reference is made to our letter, filed as correspondence via EDGAR on May 16, 2023, in which we, as representative of the underwriters in an offering pursuant to the registration statement on Form S-1 (333-271355) (the “Registration Statement”), joined Biocept, Inc.’s request for acceleration of the effective date of the above-referenced Registration Statement for May 18, 2023, at 9:00 A.M. (New York time). Biocept, Inc. is no longer requesting that such Registration Statement be declared effective at this time and we hereby formally withdraw our request for acceleration of the effective date. Very truly yours, EF HUTTON, DIVISION OF BENCHMARK INVESTMENTS, LLC By: /s/ Sam Fleischman Name: Sam Fleischman Title: Supervisory Principal